Real-life data collection for patients with Chronic Myeloid Leukemia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a large cohort of patients diagnosed with Chronic Myeloid Leukemia (CML) to collect long-term follow-up data. It will gather both prospective and retrospective clinico-biological information to facilitate various observational studies, including epidemiological analyses and treatment response evaluations. The study will also assess the impact of evolving treatment recommendations and the use of new therapeutic agents in real-life settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient diagnosed for chronic myelocytic leukemia

Exclusion Criteria:

* CML allograft without TKI treatment
* Refusal or inability to sign the consent

Where it's running

• CH Annecy Genevois
  Annecy, France Recruiting
• University Hospital, Caen
  Caen, France Recruiting
• CHU Clemront-Ferrand
  Clermont-Ferrand, France Recruiting
• Centre Hospitalier Emile Roux
  Le Puy-en-Velay, France Recruiting
• University Hospital, Limoges
  Limoges, France Recruiting
• Institut Paoli-Calmettes
  Marseille, France Recruiting

Study contacts

• Study coordinator: Lise Laclautre
• Email: promo_interne_drci@chu-clermontferrand.fr
• Phone: 04 73 75 11 95

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Asciminib for chronic phase CML with T315I mutation

  This study tests asciminib 200 mg twice daily in adults with chronic phase CML and a T315I mutation after stem cell transplant to see if it helps control leukemia.

  Recruiting at 5 sites Phase 2 University of Jena · Aachen and 9 other locations · NCT07789574

• Early Tacrolimus Taper After Allogeneic Transplant

  This study tests whether stopping tacrolimus early after an allogeneic stem cell transplant is safe and feasible for people with AML, MDS, MF, CML, CMML, or GVHD risk after transplant.

  Recruiting Phase 1 Stanford University · Palo Alto, California · NCT07302776

• Care organization and quality of life for people with chronic myeloid leukemia in the Lombardy hematology network

  This project will see if the way hematology centers are organized affects quality of life for adults with chronic myeloid leukemia in Lombardy.

  Recruiting University of Milano Bicocca · Monza, MB · NCT07165535

• Using asciminib to treat chronic myeloid leukemia patients with a specific mutation

  This study is testing if a new drug called asciminib can help people with chronic myeloid leukemia who have a specific mutation and haven't had success with other treatments.

  Recruiting at 6 sites Phase 2 Novartis · Bordeaux and 5 other locations · NCT06514534

• Second STOP After Pioglitazone Priming in CML Patients

  This phase 2 study tests whether adding pioglitazone to a TKI can help CML patients who lost major molecular response after stopping a TKI to regain disease control.

  Recruiting at 3 sites Phase 2 Versailles Hospital · Le Chesnay and 5 other locations · NCT02889003

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.